Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Randomized phase II study of nalicap (nalIRI/capecitabine) compared to NAPOLI ( nal-IRI/5F-U/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress
- Authors
- Oh, DY[Oh, Do-Youn]; Kim, JW[Kim, Jin Won]; Lee, MA[Lee, Myung Ah]; Kim, I[Kim, Ilhwan]; Lee, CK[Lee, Choong-kun]; Seol, YM[Seol, Young Mi]; Yoo, C[Yoo, Changhoon]; Oh, SC[Oh, Sang Cheul]; Bae, WK[Bae, Woo Kyun]; Chon, H[Chon, Hongjae]; Choi, IS[Choi, In Sil]; Yoon, J[Yoon, Jeesun]; Park, JO[Park, Joon Oh]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.